{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:30:17Z","timestamp":1776400217238,"version":"3.51.2"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009109","name":"Pharmaceuticals Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013412","name":"Sanofi Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.thromres.2020.07.021","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T01:59:03Z","timestamp":1594346343000},"page":"139-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Management and outcomes of cancer patients with venous thromboembolism presenting with thrombocytopenia"],"prefix":"10.1016","volume":"195","author":[{"given":"Ram\u00f3n","family":"Lecumberri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Ruiz-Artacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Trujillo-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Barillari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justo","family":"Ruiz-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel A.","family":"Lorente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Verhamme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Javier","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ido","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0494-0767","authenticated-orcid":false,"given":"Manuel","family":"Monreal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2020.07.021_bb0005","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2002-01-0108","article-title":"Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis","volume":"100","author":"Prandoni","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2020.07.021_bb0010","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1111\/j.1538-7836.2006.02082.x","article-title":"Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry","volume":"4","author":"Monreal","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2020.07.021_bb0015","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1200\/JCO.2001.19.4.1137","article-title":"Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia","volume":"19","author":"Elting","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.thromres.2020.07.021_bb0020","doi-asserted-by":"crossref","unstructured":"Carrier M, Khorana AA, Zwicker J, Noble S, Lee AY; Subcommittee on Haemostasis and Malignancy for the SSC of the ISTH. Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH. J Thromb Haemost 2013; 11: 1760\u20131765.","DOI":"10.1111\/jth.12338"},{"key":"10.1016\/j.thromres.2020.07.021_bb0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3747\/co.22.2392","article-title":"Clinical challenges in patients with cancer-associated thrombosis: Canadian expert consensus recommendations","volume":"22","author":"Carrier","year":"2015","journal-title":"Curr Oncol"},{"key":"10.1016\/j.thromres.2020.07.021_bb0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3747\/co.22.2587","article-title":"Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment","volume":"22","author":"Easaw","year":"2015","journal-title":"Curr Oncol"},{"key":"10.1016\/j.thromres.2020.07.021_bb0035","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/bjh.13556","article-title":"Guideline on aspects of cancer-related venous thrombosis","volume":"170","author":"Watson","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.thromres.2020.07.021_bb0040","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/S1470-2045(16)30369-2","article-title":"International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"17","author":"Farge","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.thromres.2020.07.021_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2017-000188","article-title":"Antithrombotic therapy for prophylaxis and treatment of venous thromboembolism in patients with cancer: review of the literature on current practice and emerging options","volume":"2","author":"Ay","year":"2017","journal-title":"ESMO Open"},{"key":"10.1016\/j.thromres.2020.07.021_bb0050","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/jth.14015","article-title":"Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH","volume":"6","author":"Samuelson Bannow","year":"2018","journal-title":"J Thromb Haemost."},{"key":"10.1016\/j.thromres.2020.07.021_bb0055","unstructured":"National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Cancer-associated venous thromboembolic disease. Version 1.2018."},{"issue":"4","key":"10.1016\/j.thromres.2020.07.021_bb0060","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1055\/s-0038-1675577","article-title":"Cancer-associated thrombosis: beyond clinical practice guidelines-a multidisciplinary (SEMI-SEOM-SETH) expert consensus","volume":"2","author":"Pach\u00f3n","year":"2018","journal-title":"TH Open"},{"key":"10.1016\/j.thromres.2020.07.021_bb0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1160\/TH10-07-0480","article-title":"Effect of the time of diagnosis on outcome in patients with acute venous thromboembolism. Findings from the RIETE Registry","volume":"105","author":"Lecumberri","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2020.07.021_bb0070","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1160\/TH13-02-0132","article-title":"Dynamics of case-fatality rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism","volume":"110","author":"Lecumberri","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2020.07.021_bb0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.amjmed.2016.10.017","article-title":"The clinical course of venous thromboembolism may differ according to cancer site","volume":"130","author":"Mah\u00e9","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.thromres.2020.07.021_bb0080","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1016\/j.thromres.2018.01.049","article-title":"Platelets, NETs and cancer","volume":"164","author":"Cerdevall","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2020.07.021_bb0085","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.thromres.2018.01.035","article-title":"Effects of platelets on cancer progression","volume":"164","author":"Plantureux","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2020.07.021_bb0090","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/1076029614543140","article-title":"Antithrombotic therapy in patients with thrombocytopenic cancer: outcomes associated with reduced-dose, low-molecular-weight heparin during hospitalization","volume":"20","author":"Babilonia","year":"2014","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.thromres.2020.07.021_bb0095","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11239-017-1478-0","article-title":"Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study","volume":"43","author":"Mantha","year":"2017","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.thromres.2020.07.021_bb0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00277-014-2198-6","article-title":"Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study","volume":"94","author":"Kopolovic","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.thromres.2020.07.021_bb0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/jth.12434","article-title":"Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH: a rebuttal","volume":"12","author":"Oo","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2020.07.021_bb0110","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11239-017-1539-4","article-title":"Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes","volume":"44","author":"Samuelson Bannow","year":"2017","journal-title":"J Thromb Thrombolysis"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820303121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820303121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:43:26Z","timestamp":1758735806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384820303121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":22,"alternative-id":["S0049384820303121"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2020.07.021","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management and outcomes of cancer patients with venous thromboembolism presenting with thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2020.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}